バイオリアクターの世界市場2019-2023

【英語タイトル】Global Bioreactors Market 2019-2023

Technavioが出版した調査資料(IRTNTR30694)・商品コード:IRTNTR30694
・発行会社(調査会社):Technavio
・発行日:2019年1月17日
・ページ数:117
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥265,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥318,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、バイオリアクターの世界市場について調査・分析し、市場概要、市場環境、バイオリアクター市場規模、エンドユーザー別(バイオ医薬品企業、研究所、受託研究機関)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・バイオリアクターの世界市場概要
・バイオリアクターの世界市場環境
・バイオリアクターの世界市場動向
・バイオリアクターの世界市場規模
・バイオリアクターの世界市場:業界構造分析
・バイオリアクターの世界市場:エンドユーザー別(バイオ医薬品企業、研究所、受託研究機関)
・バイオリアクターの世界市場:地域別市場規模・分析
・バイオリアクターの北米市場規模・予測
・バイオリアクターのヨーロッパ・中東・アフリカ市場規模・予測
・バイオリアクターのアジア太平洋市場規模・予測
・バイオリアクターの主要国分析
・バイオリアクターの世界市場:成長要因、課題
・バイオリアクターの世界市場:競争環境
・バイオリアクターの世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

About this market
The demand for single-use bioreactors has increased significantly in the global bioreactors market owing to their various attributes. Single-use bioreactors are simpler to use than stainless steel bioreactors because of the ease with which they can be set up for continuous processing. A single-use bioreactor that has been used in a fed-batch manufacturing process can be easily converted to fit the requirements of a continuous processing operation. Additionally, a single-use bioreactor enables a reduction in the maintenance costs as it does not require the same utility and piping infrastructure as a traditional stainless-steel bioreactor, which also reduces the space required within the cleanroom. Hence, the growing demand for single-use bioreactors is expected to boost the market sales of bioreactors in the long-run. Technavio’s analysts have predicted that the bioreactors market will register a CAGR of almost 7% by 2023.
Market Overview
Increased availability of accessory products
Vendors in the bioreactors market are offering accessory products with improved features and with specific manufacturing standards to make a mark in the market. The accessory products allow market vendors to retain their existing consumers and also attract new customers. Such product offerings help in attracting prospective consumers, thus leading to increased sales and high-volume production among vendors, which will support the growth of the global bioreactors market during the forecast period.
Ethical issues related to bioprocessing of stem cells for regenerative medicine
Regenerative medicine aims at restoring the structure and function of damaged organs and tissues using stem cells. Thus, amid the growing ethical concerns worldwide, animal testing must be regulated by government agencies to minimize the use of animals for research in regenerative medicine. Therefore, the existence of ethical issues pertaining to the bioprocessing of tissue samples may hamper ongoing research in stem cells, which might reduce the demand for bioreactors, and thus have a negative impact on the growth of the global bioreactors market during the forecast period.
For the detailed list of factors that will drive and challenge the growth of the bioreactors market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY END-USER
• Market segmentation by end-user
• Comparison by end-user
• Biopharmaceutical companies – Market size and forecast 2018-2023
• Research institutes – Market size and forecast 2018-2023
• Contract research organizations – Market size and forecast 2018-2023
• Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Danaher
• GE Healthcare
• Merck KGaA
• Sartorius
• Thermo Fisher Scientific
PART 13: APPENDIX

Exhibit 01: Global biotechnology market
Exhibit 02: Segments of global biotechnology market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: End-user – Market share 2018-2023 (%)
Exhibit 18: Comparison by end-user
Exhibit 19: Biopharmaceutical companies – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Biopharmaceutical companies – Year-over-year growth 2019-2023 (%)
Exhibit 21: Research institutes – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Research institutes – Year-over-year growth 2019-2023 (%)
Exhibit 23: Contract research organizations – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Contract research organizations – Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by end-user
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America – Year-over-year growth 2019-2023 (%)
Exhibit 31: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 35: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 37: Key leading countries
Exhibit 38: Market opportunity
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Danaher – Vendor overview
Exhibit 46: Danaher – Business segments
Exhibit 47: Danaher – Organizational developments
Exhibit 48: Danaher – Geographic focus
Exhibit 49: Danaher – Segment focus
Exhibit 50: Danaher – Key offerings
Exhibit 51: GE Healthcare – Vendor overview
Exhibit 52: GE Healthcare – Business segments
Exhibit 53: GE Healthcare – Organizational developments
Exhibit 54: GE Healthcare – Geographic focus
Exhibit 55: GE Healthcare – Segment focus
Exhibit 56: GE Healthcare – Key offerings
Exhibit 57: Merck KGaA – Vendor overview
Exhibit 58: Merck KGaA – Business segments
Exhibit 59: Merck KGaA – Organizational developments
Exhibit 60: Merck KGaA – Geographic focus
Exhibit 61: Merck KGaA – Segment focus
Exhibit 62: Merck KGaA – Key offerings
Exhibit 63: Sartorius – Vendor overview
Exhibit 64: Sartorius – Business segments
Exhibit 65: Sartorius – Organizational developments
Exhibit 66: Sartorius – Geographic focus
Exhibit 67: Sartorius – Segment focus
Exhibit 68: Sartorius – Key offerings
Exhibit 69: Thermo Fisher Scientific – Vendor overview
Exhibit 70: Thermo Fisher Scientific – Business segments
Exhibit 71: Thermo Fisher Scientific – Organizational developments
Exhibit 72: Thermo Fisher Scientific – Geographic focus
Exhibit 73: Thermo Fisher Scientific – Segment focus
Exhibit 74: Thermo Fisher Scientific – Key offerings




【掲載企業】

Danaher、GE Healthcare、Merck KGaA、Sartorius、Thermo Fisher Scientific

★調査レポート[バイオリアクターの世界市場2019-2023] (コード:IRTNTR30694)販売に関する免責事項を必ずご確認ください。
★調査レポート[バイオリアクターの世界市場2019-2023]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆